Harrisburg, PA - The Department of Health has opened the application process for expanded research into the use of Cannabidiol (CBD) for the treatment of children with intractable seizures.
Qualified research facilities are invited to compete for $2 million in funding from the Commonwealth Universal Research Enhancement Program (CURE) to support the study of CBD in treating children with epilepsy and other neurological diseases who suffer from medication-resistant seizures.
In November 2014, $2 million in CURE funding from the Tobacco Master Settlement Agreement of 1998 was placed in budgetary reserve for so-called “non-formula” priorities.
Following the success of several small pilot studies, the Department of Health determined that the continued study of CBD for the treatment of seizure frequency would be a priority for the agency.
“Treatment-resistant seizures are especially tragic when they affect children. The inability to control or stop seizure activity has a devastating impact on quality of life of pediatric patients,” said Health Secretary Karen Murphy.
Read more
